| Literature DB >> 33996174 |
Milan Gautam1, Jong Oh Kim1, Chul Soon Yong1.
Abstract
BACKGROUND: Traditionally, nanoparticles for biomedical applications have been produced via the classical wet chemistry method, with size control remaining a major problem in drug delivery. In recent years, advances in aerosol-based technologies have led to the development of methods that enable the production of nanosized particles and have opened up new opportunities in the field of nano-drug delivery and biomedicine. Aerosol-based technologies have been constantly used to synthesize multifunctional nanoparticles with different properties, which extends their possible biological and medicinal applications. Moreover, aerosol technologies are often more beneficial than other existing approaches because of the major disadvantages of these other techniques. AREA COVERED: This review provides a brief discussion of the existing aerosol-based nanotechnologies and applications of nanoparticles in a variety of diseases. Various types of nanoparticles, such as graphene oxide, Prussian blue, black phosphorous, gold, copper, silver, tellurium, iron oxide, titania, magnesium oxide, and zinc oxide nanoparticles, prepared using aerosol technologies are discussed in this review. The different tactics used for surface modifications are also outlined. The biomedical applications of nanoparticles in chemotherapy, bacterial/fungal/viral treatment, disease diagnosis, and biological assays are also presented in this review. EXPERT OPINION: Aerosol-based technologies can be used to design nanoparticles with the desired functionality. This significantly benefits the nanomedicine field, particularly as product parameters are becoming more encompassing and exacting. One of the biggest issues with conventional methods is their scale-up/scale-down and clinical translation. Aerosol-based nanoparticle synthesis helps enhance control over the product properties and facilitate their use for clinical applications. © The Korean Society of Pharmaceutical Sciences and Technology 2021.Entities:
Keywords: Aerosol; Atomization; Biomedical; Pyrolysis; Spark discharge; Theragnostic
Year: 2021 PMID: 33996174 PMCID: PMC8113021 DOI: 10.1007/s40005-021-00523-1
Source DB: PubMed Journal: J Pharm Investig ISSN: 2093-5552
Fig. 1A schematic diagram of the experimental apparatus for the synthesis of silica nanoparticles via flame spray pyrolysis using a two-fluid nozzle spray. The given figure was adopted from Chang et al. (2008)
Fig. 2Ambient heterogeneous spark discharge to synthesize Au–TiO2 heterodimers in a gaseous phase for photocatalytic and photothermal applications. The given figure was adopted from Byeon and Kim (2014)
Fig. 3Schematic of spark ablation used to prepare Ag or Cu-doped Te nanoparticles from three Ag or Cu anodes (green) and a Te cathode (red) inside a chamber under a nitrogen gas flow. The given figure was adopted from Park et al. (2019)
Fig. 4Schematic of the preparation of nanoparticles via flame spray pyrolysis. The given figure was adopted from Bettini et al. (2015)
Fig. 5Schematic of the aero–hydro–aero route to produce graphene oxide-patched titania nanoparticles for chemo-phototherapeutic applications. The given figure was adopted from Gautam et al. (2018)
Fig. 6Biological applications of aerosol-based nanocomposites
Fig. 7Different mechanisms of the antimicrobial action of nanoparticles. The given figure was adopted from Jamdagni et al. (2018)
List of different formulations used for the treatment of various diseases
| Preparation/delivery technique | Formulation | Application/treatment | References |
|---|---|---|---|
| Collison-type atomizer | BP-H-ILsi-X@EM-YSA | Colon adenocarcinoma (MC-38) | (Ou et al. |
| Spark discharge and surface modification | S-MTN@IG-P | Colon cancer (HT-29 and HCT-116) | (Gautam et al. |
| Spark discharge and surface modification | PB-Dpeg@nGO | Pancreatic cancer (PANC-1) | (Gautam et al. |
| Single-pass gas-phase self-assembly | nGO@DOX-cPEG | PC3, DU145, and LNCaP tumor cells | (Thapa et al. |
| Spark ablation | BP@DHCA | Human skin cancers (B-16) | (Nguyen et al. |
| Green aerosol | Ag-nanoparticles | (Hontanon et al. | |
| Gas–liquid green route | Chitosan-capped Cu-Ag nanobunches | (Byeon | |
| Spark plasma reactor and flow heater | Cu−Te (RT, 400 °C, or 800 °C) NPs | (Gautam et al. | |
| Single-pass gas-to-liquid process | Ag-SNP@TRP and Ag-CNT@TRP | (Poudel et al. | |
| Spray-congealing with wide pneumatic nozzle | Polymer–lipid mucoadhesive microspheres | (Albertini et al. | |
| Aerosol | Aerosolized amphotericin B | Antifungal prophylaxis in the early post lung transplantation | (Drew et al. |
| Aerosol | Amphotericin B liposome | Prevention of invasive pulmonary aspergillosis in neutropenia | (Rijnders et al. |
| Transdermal spray | Voriconazole transdermal spray | (Mori et al. | |
| Inhalable dry powder | Controlled Release Voriconazole Dry Powder | Invasive pulmonary aspergillosis | (Arora et al. |
| Ionic gelation using spray drying technique | Itraconazole encapsulated chitosan-based dry powder | Pulmonary drug delivery for fungal infection | (Jafarinejad et al. |